Xenetic Biosciences (XBIO) EBITDA (2011 - 2026)
Xenetic Biosciences (XBIO) EBITDA from Nov 30, 2011 to Mar 31, 2026. The TTM Xenetic Biosciences (XBIO) EBITDA is -$2.24M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Xenetic Biosciences (XBIO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -38.80% |
| 3 Years TTM | -27.91% |
| 5 Years TTM | -30.75% |
| 10 Years TTM | -13.72% |
| All Time TTM | +26.27% |
Annual EBITDA change of Xenetic Biosciences (XBIO)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$460K | -82.84% |
| 2025 | -$2.68M | -32.32% |
| 2024 | -$3.96M | -4.12% |
| 2023 | -$4.13M | -38.54% |
| 2022 | -$6.72M | +16.87% |
| 2021 | -$5.75M | -58.75% |
| 2020 | -$14M | +8.23% |
| 2019 | -$13M | +77.41% |
| 2018 | -$7.26M | +105.08% |
| 2017 | -$3.54M | -92.53% |
| 2016 | -$47M | +385.06% |
| 2015 | -$9.77M | -23.91% |
| 2014 | -$13M | +50.00% |
| 2013 | -$8.56M | +37.18% |
| 2012 | -$6.24M | +62300.00% |
| 2011 | -$10K | N/A |
Comparison Xenetic Biosciences (XBIO) five years EBITDA CAGR with competitors
Xenetic Biosciences (XBIO) five years EBITDA CAGR is -30.80%.